Kelley-Seegmiller syndrome due to a unique variant of hypoxanthine-guanine phosphoribosyltransferase: reduced affinity for 5-phosphoribosyl-1-pyrophosphate manifested only at low, physiological substrate concentrations.
A male child, who presented at the age of 3.5 years with acute renal failure, was diagnosed as having partial deficiency of hypoxanthine-guanine phosphoribosyltransferase (HPRT; EC 2.4.2.8). The underlying HPRT mutation was unique in that the specific activity of HPRT in erythrocyte and in fibroblast lysates was normal, but the rate of uptake of hypoxanthine into nucleotides of intact cultured fibroblasts was markedly reduced (23% of normal). The low functioning of HPRT in the intact fibroblasts was associated with decreased utilization of endogenously generated hypoxanthine and with decreased utilization of the cosubstrate 5-phosphoribosyl-1-pyrophosphate (PRPP). The non-utilized hypoxanthine was excreted into the incubation medium. The accumulation of PRPP was indicated by the 2.3-fold increase in the rate of uptake of adenine into intact cell nucleotides and by the 7. 5-fold enhancement of the rate of de novo purine synthesis. Kinetic studies of HPRT activity in fibroblast lysates revealed reduced affinity of the enzyme for PRPP (apparent K(m) 500 microM in comparison to 25 microM in control lysates), manifested in low activity at low (physiological), but not at high PRPP concentrations. The apparent K(m) for hypoxanthine was normal (23 microM in comparison to 14.2 microM in control lysates). With allopurinol treatment, our patient has had no problems since presentation, and is developing normally at 5 years of age.
Zoref-Shani
E
E
Department of Clinical Biochemistry, Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.
Feinstein
S
S
Frishberg
Y
Y
Bromberg
Y
Y
Sperling
O
O
D058186:Acute Kidney Injury / Q000201:enzymology / Q000235:genetics*; D000225:Adenine / Q000378:metabolism; D002478:Cells, Cultured; D002675:Child, Preschool; D017077:Culture Media, Conditioned; D004252:DNA Mutational Analysis; D005347:Fibroblasts / Q000201:enzymology; D006073:Gout / Q000201:enzymology / Q000235:genetics; D006801:Humans; D019271:Hypoxanthine / Q000378:metabolism*; D007041:Hypoxanthine Phosphoribosyltransferase / Q000097:blood / Q000737:chemistry / Q000172:deficiency* / Q000235:genetics; D007585:Jews / Q000235:genetics; D008214:Lymphocytes / Q000201:enzymology; D008297:Male; D009696:Nucleic Acids / Q000096:biosynthesis; D009711:Nucleotides / Q000096:biosynthesis; D010754:Phosphoribosyl Pyrophosphate / Q000378:metabolism; D011687:Purines / Q000096:biosynthesis; D013577:Syndrome; D014527:Uric Acid / Q000097:blood / Q000652:urine
D017077:Culture Media, Conditioned; D009696:Nucleic Acids; D009711:Nucleotides; D011687:Purines; D014527:Uric Acid; D019271:Hypoxanthine; D010754:Phosphoribosyl Pyrophosphate; D007041:Hypoxanthine Phosphoribosyltransferase; D000225:Adenine